BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talwalkar JA, Kamath PS. Influence of Recent Advances in Medical Management on Clinical Outcomes of Cirrhosis. Mayo Clinic Proceedings 2005;80:1501-8. [DOI: 10.4065/80.11.1501] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Anaparthy R, Talwalkar JA, Yin M, Roberts LR, Fidler JL, Ehman RL. Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. Aliment Pharmacol Ther 2011;34:83-91. [PMID: 21535445 DOI: 10.1111/j.1365-2036.2011.04673.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
2 Grebely J, Talwalkar JA. Recognizing and preventing death from compensated cirrhosis in the community. Liver Int 2012;32:2-4. [PMID: 22098367 DOI: 10.1111/j.1478-3231.2011.02627.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Shi HB, Kong M, Chen G, Zhao J, Shi HL, Chen Y, Rowan FG. Compound Pollen Protein Nutrient Increases Serum Albumin in Cirrhotic Rats. Gastroenterology Res 2010;3:253-61. [PMID: 27942305 DOI: 10.4021/gr240e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Ollivier I, Dauvois B, Guittet L, Boutreux S, Dupont B, Launoy G, Dao T. Survival improvement in Child–Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990–2002. Gastroentérologie Clinique et Biologique 2010;34:288-96. [DOI: 10.1016/j.gcb.2010.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Haj M, Rockey DC. Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018;34:266-271. [PMID: 29846263 DOI: 10.1097/mog.0000000000000450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
6 Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707-1715. [PMID: 18691193 DOI: 10.1111/j.1572-0241.2008.01861.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 13.0] [Reference Citation Analysis]
7 Wang J, Wang Q, Yu G, She Q, Zhang W, Zhang J. Correlation Between Liver Stiffness Measured by Shear Wave Elastography and Child-Pugh Classification. J Ultrasound Med 2018;37:2191-9. [PMID: 29476558 DOI: 10.1002/jum.14569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Basu PP, Shah NJ. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Clin Liver Dis. 2015;19:461-472. [PMID: 26195201 DOI: 10.1016/j.cld.2015.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
9 Lopez AD, Williams TN, Levin A, Tonelli M, Singh JA, Burney PG, Rehm J, Volkow ND, Koob G, Ferri CP. Remembering the forgotten non-communicable diseases. BMC Med 2014;12:200. [PMID: 25604462 DOI: 10.1186/s12916-014-0200-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
10 Cowgill SM, Thometz D, Clark W, Villadolid D, Carey E, Pinkas D, Zervos E, Rosemurgy A. Conventional Predictors of Survival Poorly Predict and Significantly Underpredict Survival after H-graft Portacaval Shunts. J Gastrointest Surg 2007;11:89-94. [DOI: 10.1007/s11605-006-0041-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596-604. [PMID: 18000989 DOI: 10.1002/hep.22032] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 8.1] [Reference Citation Analysis]
12 Giannini EG, Moscatelli A, Pellegatta G, Vitale A, Farinati F, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Baroni GS, Virdone R, Masotto A, Trevisani F; Italian Liver Cancer (ITA. LI.CA) Group; Italian Liver Cancer ITA LI CA Group. Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma. Am J Gastroenterol. 2016;111:70-77. [PMID: 26729544 DOI: 10.1038/ajg.2015.389] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
13 Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol. 2007;102:754-760. [PMID: 17222319 DOI: 10.1111/j.1572-0241.2007.01048.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 7.2] [Reference Citation Analysis]
14 Long B, Koyfman A. The emergency medicine evaluation and management of the patient with cirrhosis. The American Journal of Emergency Medicine 2018;36:689-98. [DOI: 10.1016/j.ajem.2017.12.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology 2007;45:1282-9. [PMID: 17464970 DOI: 10.1002/hep.21580] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
16 Pepin KM, Ehman RL, McGee KP. Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. Prog Nucl Magn Reson Spectrosc 2015;90-91:32-48. [PMID: 26592944 DOI: 10.1016/j.pnmrs.2015.06.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
17 Mantry PS, Munsaf S. Rifaximin for the treatment of hepatic encephalopathy. Transplant Proc. 2010;42:4543-4547. [PMID: 21168733 DOI: 10.1016/j.transproceed.2010.09.173] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
18 Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2006;4:1378-1384. [PMID: 17059899 DOI: 10.1016/j.cgh.2006.08.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
19 Poo JL, Góngora J, Sánchez-ávila F, Aguilar-castillo S, García-ramos G, Fernández-zertuche M, Rodríguez-fragoso L, Uribe M. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. Annals of Hepatology 2006;5:281-8. [DOI: 10.1016/s1665-2681(19)31989-1] [Cited by in Crossref: 51] [Article Influence: 3.2] [Reference Citation Analysis]
20 Liu YM, Shi HB, Liu YR, Shi HL, Ren F, Chen Y, Chen DX, Lou JL, Duan ZP. Protective Effect of Ganshuang Granules () on Liver Cirrhosis by Suppressing Regulatory T Cells in Mouse Model. Chin J Integr Med 2019;25:51-8. [PMID: 26542309 DOI: 10.1007/s11655-015-2430-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
21 Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F. Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroenterol Hepatol. 2009;7:580-585. [PMID: 19418607 DOI: 10.1016/j.cgh.2009.01.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
22 Bajaj JS. Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 2008; 14(23): 3609-3615 [PMID: 18595126 DOI: 10.3748/wjg.14.3609] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
23 Giannini EG. Safety of cardiac surgery in cirrhotic patients: going to the heart of the matter. Clin Gastroenterol Hepatol 2012;10:450-1. [PMID: 22289870 DOI: 10.1016/j.cgh.2012.01.009] [Reference Citation Analysis]
24 Thuluvath PJ, Nuthalapati A, Price J, Maheshwari A. Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments. J Clin Exp Hepatol 2016;6:3-9. [PMID: 27194889 DOI: 10.1016/j.jceh.2015.09.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010;7:515-25. [DOI: 10.1038/nrgastro.2010.116] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
26 Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F. Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it? World J Gastroenterol 2013; 19(47): 8808-8821 [PMID: 24379604 DOI: 10.3748/wjg.v19.i47.8808] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
27 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Talwalkar JA. Functional hepatic imaging and disease recurrence after liver transplantation. Liver Transpl 2006;12:1744-6. [DOI: 10.1002/lt.20891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Zhang YB. Progress in understanding the pathogenesis of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2012; 20(25): 2358-2363 [DOI: 10.11569/wcjd.v20.i25.2358] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Fowler C. Management of patients with complications of cirrhosis. The Nurse Practitioner 2013;38:14-22. [DOI: 10.1097/01.npr.0000427610.76270.45] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci. 2012;57:189-195. [PMID: 21842240 DOI: 10.1007/s10620-011-1858-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
32 Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, Ripoll C, Maurer R, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Makuch R, Rendon G; Portal Hypertension Collaborative Group. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689-695. [PMID: 19281860 DOI: 10.1016/j.cgh.2009.02.021] [Cited by in Crossref: 136] [Cited by in F6Publishing: 121] [Article Influence: 10.5] [Reference Citation Analysis]
33 Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol. 2008;8:3. [PMID: 18261240 DOI: 10.1186/1471-230x-8-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
34 Chen BB, Shih TTF. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker. World J Gastroenterol 2014; 20(12): 3125-3134 [PMID: 24695624 DOI: 10.3748/wjg.v20.i12.3125] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
35 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008;2:785-790. [PMID: 19090738 DOI: 10.1586/17474124.2.6.785] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
37 Bajaj JS, Thacker LR, Wade JB, Sanyal AJ, Heuman DM, Sterling RK, Gibson DP, Stravitz RT, Puri P, Fuchs M. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123-1132. [PMID: 21929591 DOI: 10.1111/j.1365-2036.2011.04842.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
38 Nguyen GC, Segev DL, Thuluvath PJ. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol. 2007;5:1092-1099. [PMID: 17625983 DOI: 10.1016/j.cgh.2007.04.027] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 4.5] [Reference Citation Analysis]